USPTO Examiner SKIBINSKY ANNA - Art Unit 1635

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19187919METHOD AND SYSTEM FOR IDENTIFYING SMALL MOLECULE BINDERS WITHIN DNA-ENCODED LIBRARY DATASETApril 2025November 2025Allow610YesNo
18617486SYSTEMS AND METHODS FOR ASSOCIATING COMPOUNDS WITH PROPERTIES USING CLIQUE ANALYSIS OF CELL-BASED DATAMarch 2024March 2025Allow1220NoNo
18600486DEEP GENERATIVE MODELS FOR INVERSE DESIGN OF INORGANIC ATOMISTIC STRUCTURESMarch 2024July 2025Abandon1611NoNo
18592300METHOD AND APPARATUS FOR REDUCING CHEMICAL REACTION MECHANISMSFebruary 2024January 2026Abandon2220YesNo
18519995COMPOSITIONS AND METHODS FOR EXPRESSING GENES OF INTEREST IN HOST CELLSNovember 2023September 2024Allow1021YesNo
18513348FUNCTION GUIDED IN SILICO PROTEIN DESIGNNovember 2023August 2024Allow811YesNo
18509632SYSTEM AND METHOD FOR PREDICTING SUSCEPTIBILITY OF GENUS KLEBSIELLA TO AMIKACINNovember 2023June 2024Allow720NoNo
18507527ACTIVATION OF APPLIANCE IN RESPONSE TO SUBJECT SLEEP STATENovember 2023November 2025Allow2420NoNo
18382945SYSTEM AND METHOD FOR PROTEIN SELECTIONOctober 2023September 2025Abandon2211NoNo
18479524METHODS AND SYSTEMS FOR USING DEEP LEARNING TO PREDICT PROTEIN-LIGAND COMPLEX STRUCTURES IN PROTEIN FOLDING AND PROTEIN-LIGAND CO-FOLDINGOctober 2023August 2024Allow1011YesNo
18459180METHOD AND SYSTEM FOR PROVIDING GENETIC INFORMATION ANALYSIS RESULTSAugust 2023June 2025Allow2140YesNo
18453990METHYLATION-BASED FALSE POSITIVE DUPLICATE MARKING REDUCTIONAugust 2023January 2025Abandon1710YesNo
18233738HOMELAND EXPLOSIVE CONSEQUENCE AND THREAT (HEXCAT) MODELING AND MEDICAL MITIGATION TOOLAugust 2023October 2024Allow1410NoNo
18353829METHODS, APPARATUSES, AND TOOLS FOR SEMI-AUTOMATED DIGITAL SUPPORT AND STRUCTURED DATA CAPTURE FOR THE MULTI-DIMENSIONAL MANUAL PROCESS OF CELL CULTURE MAINTENANCE AND MANIPULATION ENABLING ARTIFICIAL INTELLIGENCE (AI) DRIVEN PREDICTION AND CONTROLLED DATA SHARINGJuly 2023April 2025Allow2120NoNo
18335875SYSTEMS AND METHODS FOR PREDICTING RESULTS OF A MANUFACTURING PROCESS FOR GENERATING BIOLOGICAL STRUCTURESJune 2023July 2024Allow1320YesNo
18329431SYSTEMS AND METHODS FOR EPIGENETIC ANALYSISJune 2023March 2025Allow2210NoNo
18324799SYSTEMS AND METHODS FOR ANALYZING VIRAL NUCLEIC ACIDSMay 2023August 2024Allow1510NoNo
18202050SYSTEMS, METHODS, AND APPARATUS FOR INDUCED PLURIPOTENT STEM CELL ISOLATION AND COMBINATORIAL PRODUCTIONMay 2023December 2025Abandon3121NoNo
18316939SYSTEMS AND METHODS FOR GROUPING AND COLLAPSING SEQUENCING READSMay 2023June 2024Allow1410NoNo
18312821METHOD FOR IMPROVING DISEASE DIAGNOSIS USING MEASURED ANALYTESMay 2023May 2025Abandon2520NoNo
18132353SYSTEMS AND METHODS FOR MITOCHONDRIAL ANALYSISApril 2023December 2024Abandon2020NoNo
18188028METHOD FOR EVALUATING DISTRIBUTION OF INFECTED PERSONS IN AREAMarch 2023February 2024Abandon1110YesNo
18186747SYSTEM, METHOD, AND ARTICLE FOR DETECTING ABNORMAL CELLS USING MULTI-DIMENSIONAL ANALYSISMarch 2023July 2025Allow2720NoNo
18043528IMPLEMENTING A GENERATIVE MACHINE LEARNING ARCHITECTURE TO PRODUCE TRAINING DATA FOR A CLASSIFICATION MODELFebruary 2023April 2024Allow1411YesNo
18095339SYSTEM AND METHOD FOR PROTEIN SELECTIONJanuary 2023September 2023Allow820YesNo
18089319SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED BINDING SITE PREDICTION AND SEARCH SPACE FILTERING FOR BIOLOGICAL SCAFFOLD DESIGNDecember 2022April 2024Allow1611NoNo
18077016METHOD AND SYSTEM FOR ANALYZING SEQUENCESDecember 2022July 2023Allow710YesNo
18075387SYSTEMS AND METHODS FOR INFERRING GENETIC ANCESTRY FROM LOW-COVERAGE GENOMIC DATADecember 2022February 2024Allow1510YesNo
18070282SYSTEMS AND METHODS FOR GENE EXPRESSION ANALYSISNovember 2022May 2025Abandon3021NoNo
17929836MASS SPECTROMETRIC IDENTIFICATION OF MICROORGANISMS IN COMPLEX SAMPLESSeptember 2022April 2024Abandon1930YesYes
17901778ALIGNMENT FREE FILTERING FOR IDENTIFYING FUSIONSSeptember 2022November 2024Abandon2620YesNo
17894669COMPUTATIONAL SYSTEMS AND METHODS FOR IMPROVING THE ACCURACY OF DRUG TOXICITY PREDICTIONSAugust 2022December 2023Allow1510NoNo
17821044Selection and Monitoring Methods for XenotransplantationAugust 2022November 2024Abandon2620NoNo
17841536SYSTEMS AND METHODS FOR ASSOCIATING COMPOUNDS WITH PROPERTIES USING CLIQUE ANALYSIS OF CELL-BASED DATAJune 2022March 2024Allow2130YesNo
17804963COMBINED PHYSIOLOGICAL SENSOR SYSTEMS AND METHODSJune 2022January 2025Allow3130YesNo
17743367Data Processing Device and Method for the Evaluation of Mass Spectrometry DataMay 2022December 2025Allow4330NoNo
17770000A UNIFIED PORTAL FOR REGULATORY AND SPLICING ELEMENTS FOR GENOME ANALYSISApril 2022March 2025Abandon3521YesNo
17670380SYSTEMS AND METHODS FOR DETECTING RECOMBINATIONFebruary 2022March 2025Allow3720NoNo
17668314CANCER DETECTION AND CLASSIFICATION USING METHYLOME ANALYSISFebruary 2022January 2023Abandon1110NoNo
17580785DETECTOR, DETECTION METHOD, AND PROGRAMJanuary 2022March 2026Abandon4910NoNo
17577078ASSESSMENT OF THE P13K CELLULAR SIGNALING PATHWAY ACTIVITY USING MATHEMATICAL MODELLING OF TARGET GENE EXPRESSIONJanuary 2022March 2024Abandon2610YesNo
17576471Homeland Explosive Consequence and Threat (HExCAT) Modeling ToolJanuary 2022May 2023Allow1620YesNo
17553498MACHINE LEARNING TECHNIQUES FOR IDENTIFYING MALIGNANT B- AND T-CELL POPULATIONSDecember 2021September 2023Abandon2120NoNo
17617665A DEEP LEARNING MODEL FOR PREDICTING TUMOR-SPECIFIC NEOANTIGEN MHC CLASS I OR CLASS II IMMUNOGENICITYDecember 2021October 2025Allow4710NoNo
17536046METHOD AND APPARATUS FOR COMPRESSING FASTQ DATA THROUGH CHARACTER FREQUENCY-BASED SEQUENCE REORDERINGNovember 2021February 2026Allow5120NoNo
17531438Community Assignments in Identity by Descent Networks and Genetic Variant OriginationNovember 2021January 2024Allow2610YesNo
17527239APPARATUS, METHODS AND COMPUTER PROGRAMS FOR DETERMINING ELECTRICAL OUTPUT SIGNALS FOR BIOLOGICAL SAMPLESNovember 2021January 2026Abandon5010NoNo
17502339METHOD AND SYSTEM FOR PREDICTING RESPONSE TO IMMUNE ANTICANCER DRUGSOctober 2021June 2025Allow4420YesNo
17469600SURGICAL GUIDANCE AND PLANNING SOFTWARE FOR ASTIGMATISM TREATMENTSeptember 2021March 2024Abandon3030YesNo
17427786SYSTEMS, METHODS, AND MEDIA FOR MOLECULE DESIGN USING MACHINE LEARNING MECHANISMSAugust 2021December 2025Allow5310NoNo
17421420METHOD FOR DETERMINING RESPONSIVENESS TO AN EPITOPEJuly 2021March 2026Abandon5610NoNo
17351420SYSTEMS AND METHODS FOR MODELLING A HUMAN SUBJECTJune 2021February 2026Abandon5610NoNo
17415680A METHOD OF FINDING A TARGET ENVIRONMENT SUITABLE FOR GROWTH OF A PLANT VARIETYJune 2021May 2025Abandon4701NoNo
17415330METHOD AND DEVICE FOR CREATING A CONTINUOUS COURSE AND FOR PREDICTING THE FLUID BALANCE OF A PATIENTJune 2021February 2026Abandon5610NoNo
17346865METHOD AND DEVICE FOR DESIGNING TARGET-SPECIFIC DRUG IN WHICH DEEP-LEARNING ALGORITHM IS COMBINED WITH WATER PHARMACOPHORE MODELJune 2021October 2025Allow5210NoNo
17344593METHODS OF SCREENING AND RELATED SYSTEMSJune 2021January 2026Abandon5511NoNo
17311718METHOD AND SYSTEM FOR PROVIDING CANCER DIAGNOSIS INFORMATION USING ARTIFICIAL INTELLIGENCE-BASED LIQUID BIOPSY OF EXOSOMEJune 2021September 2025Allow5220NoNo
17337786Selection and Monitoring Methods for XenotransplantationJune 2021April 2022Allow1020YesNo
17332674Automated Monitoring and Retraining of Infectious Disease Computer ModelsMay 2021December 2025Abandon5520YesNo
17315335METHOD FOR ANALYSIS OF DRUG MOLECULAR DYNAMICS RESULTS BASED ON ROOT-MEAN-SQUARE DEVIATION MULTIPLE FEATURESMay 2021June 2022Abandon1320YesNo
17313525SYNTHETIC TUMOR MODELS FOR USE IN THERAPEUTIC RESPONSE PREDICTIONMay 2021September 2025Abandon5201NoNo
17307644METHOD FOR EVALUATING PANCREATIC CANCER, PANCREATIC CANCER EVALUATING APPARATUS, PANCREATIC CANCER EVALUATING METHOD, PANCREATIC CANCER EVALUATING PROGRAM PRODUCT, PANCREATIC CANCER EVALUATING SYSTEM AND INFORMATION COMMUNICATION TERMINAL APPARATUSMay 2021July 2024Allow3820NoNo
17288113COLORED COIN HAVING INDIVIDUAL GENE PHENOTYPE APPLIED THERETOApril 2021April 2025Abandon4820NoNo
17288053Heart Rate Detection Method, Heart Rate Detection Device and ProgramApril 2021July 2025Abandon5020YesNo
17221405DECODING APPROACHES FOR PROTEIN IDENTIFICATIONApril 2021April 2023Abandon2540YesNo
17281264AI-BASED CONDITION CLASSIFICATION SYSTEM FOR PATIENTS WITH NOVEL CORONAVIRUSMarch 2021April 2025Allow4810NoNo
17277514CHEMICAL COMPUTERMarch 2021May 2025Allow5020NoNo
17200281METHOD AND APPARATUS OF CHEMISTRY EDUCATIONMarch 2021February 2025Allow4710YesNo
17047632Method and Device for Actuating an Analysis Device for Running an Analysis on a Sample MaterialFebruary 2021March 2025Abandon5320NoNo
17180433EARLY LUNG CANCER DETECTION BY DNA METHYLATION PHENOTYPING OF SPUTUM-DERIVED CELLSFebruary 2021March 2023Allow2510NoNo
17150187SYSTEMS AND METHODS FOR ADJUSTING TRAINING DATA BASED ON SENSOR DATAJanuary 2021September 2025Allow5620YesNo
17260281METHOD FOR PREDICTING A MOLECULAR WEIGHT DISTRIBUTION OF A BIOPOLYMER BLENDJanuary 2021October 2025Abandon5820NoNo
17248083SYSTEMS AND METHODS FOR DETECTING HOMOPOLYMER INSERTIONS/DELETIONSJanuary 2021December 2024Abandon4721NoNo
17126420METHOD AND APPARATUS OF PROVIDING OSTEOARTHRITIS PREDICTION INFORMATIONDecember 2020April 2025Abandon5220NoNo
17113790LIVING BIOSENSORSDecember 2020October 2024Allow4741YesNo
16972552MORPHOMETRIC DETECTION OF DNA MISMATCH REPAIR DEFICIENCYDecember 2020March 2026Allow6021YesNo
15734527METHOD, APPARATUS, AND DEVICE FOR SIMULATING A TRAVEL PATH OF A CATHETER IN A BLOOD VESSELDecember 2020August 2024Allow4420YesNo
17093571SYSTEM, METHOD, AND COMPUTER SOFTWARE PRODUCT FOR GENOTYPE DETERMINATION USING PROBE ARRAY DATANovember 2020December 2023Abandon3710NoNo
17049101METHOD FOR THE DETERMINATION OF PROCESSING INFLUENCES ON THE ENERGY VALUE OF FEEDSTUFF RAW MATERIALS AND/OR FEEDSTUFFSOctober 2020September 2025Allow5930YesNo
17061156METHOD, APPARATUS, AND PROGRAM FOR EVALUATION OF ANY ONE OR BOTH OF HEALTH STATE AND GROWTH STATE OF LIVESTOCK ANIMALOctober 2020January 2026Allow6030YesNo
17034041FECAL SAMPLE AND/OR BREATH SAMPLE ANALYSIS FOR TREATING INFLAMMATORY BOWEL DISEASE AND RELATED CONDITIONSSeptember 2020August 2025Abandon5920NoNo
16981431METHOD OF DIAGNOSING CELIAC DISEASESeptember 2020October 2024Abandon4910NoNo
17023289SYSTEMS AND METHODS FOR EPIGENETIC ANALYSISSeptember 2020February 2023Allow2910NoNo
17018629MULTICELLULAR METABOLIC MODELS AND METHODSSeptember 2020July 2023Abandon3510NoNo
17012153PERFORMING PHARMACODYNAMICS EVALUATIONS USING MICROFLUIDIC DEVICESSeptember 2020September 2025Allow6041YesNo
15733547A COMPUTER-IMPLEMENTED METHOD OF ANALYSING GENETIC DATA ABOUT AN ORGANISMAugust 2020April 2025Allow5620YesNo
16996792METHOD FOR IDENTIFYING AND QUANTIFYING POPULATIONS EXPOSED TO ENVIRONMENTAL HAZARDS ACROSS A GEOGRAPHIC REGIONAugust 2020May 2024Abandon4421NoNo
16969072CT BIG DATA FROM SIMULATION, EMULATION AND TRANSFER LEARNINGAugust 2020August 2024Allow4810NoNo
16987329DISCOVERY OF BIOLOGICAL SIGNATURES OF OPTIMIZED SENSITIVITY AND SPECIFICITYAugust 2020June 2023Allow3421YesNo
16965222COMPUTATIONAL GENERATION OF CHEMICAL SYNTHESIS ROUTES AND METHODSJuly 2020December 2023Allow4061YesNo
16937827SYSTEMS AND METHODS FOR ANALYZING VIRAL NUCLEIC ACIDSJuly 2020February 2023Allow3110YesNo
16930213SYSTEM AND METHOD FOR RECOMMENDING PARAMETERS FOR A SURGICAL PROCEDUREJuly 2020October 2024Abandon5110NoNo
16923014CLINICAL DECISION MODELJuly 2020August 2025Allow6030NoNo
16918000PATHOGEN DISTRIBUTION INFORMATION PROVISION SYSTEM, PATHOGEN DISTRIBUTION INFORMATION PROVISION SERVER, AND METHOD FOR PROVIDING PATHOGEN DISTRIBUTION INFORMATIONJuly 2020March 2024Allow4510YesNo
16771558PRE-SURGICAL RISK STRATIFICATION BASED ON PDE4D7 EXPRESSION AND PRE-SURGICAL CLINICAL VARIABLESJune 2020April 2024Allow4611NoNo
16896877SYSTEMS, METHODS, AND APPARATUSES TO PREDICT PAIRS OF ENZYME PRIMARY SEQUENCES AND SUBSTRATES AND AN INTERACTION PROBABILITY FOR EACH PREDICTED PAIRJune 2020November 2023Allow4111YesNo
16894028METHODS FOR PLACING, ACCEPTING, AND FILLING ORDERS FOR PRODUCTS AND SERVICESJune 2020March 2024Abandon4610YesNo
16768042INCORPORATION OF FUSION GENES INTO PPI NETWORK TARGET SELECTION VIA GIBBS HOMOLOGYMay 2020June 2023Abandon3710NoNo
16871833INTERLEUKIN-18 MIMICS AND METHODS OF USEMay 2020February 2024Allow4511NoNo
16762371METHOD FOR SIMULTANEOUS MULTIVARIATE FEATURE SELECTION, FEATURE GENERATION, AND SAMPLE CLUSTERINGMay 2020June 2024Abandon4910NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SKIBINSKY, ANNA.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
13
Examiner Affirmed
11
(84.6%)
Examiner Reversed
2
(15.4%)
Reversal Percentile
26.9%
Lower than average

What This Means

With a 15.4% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
27
Allowed After Appeal Filing
6
(22.2%)
Not Allowed After Appeal Filing
21
(77.8%)
Filing Benefit Percentile
29.1%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 22.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SKIBINSKY, ANNA - Prosecution Strategy Guide

Executive Summary

Examiner SKIBINSKY, ANNA works in Art Unit 1635 and has examined 174 patent applications in our dataset. With an allowance rate of 62.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 50 months.

Allowance Patterns

Examiner SKIBINSKY, ANNA's allowance rate of 62.1% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SKIBINSKY, ANNA receive 2.51 office actions before reaching final disposition. This places the examiner in the 73% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SKIBINSKY, ANNA is 50 months. This places the examiner in the 5% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +29.5% benefit to allowance rate for applications examined by SKIBINSKY, ANNA. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.0% of applications are subsequently allowed. This success rate is in the 27% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 25.0% of cases where such amendments are filed. This entry rate is in the 33% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 44.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 40% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 45.8% of appeals filed. This is in the 11% percentile among all examiners. Of these withdrawals, 63.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 67.5% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 5.7% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.